In August, we added 101 citations in DIDB, including 53 in vitro (with 21 articles published in Aug 2026) and 48 in vivo articles (with 28 articles published in Aug 2026). Five NDAs approved by the FDA from May to July in 2026, including baxdrostat (BAXFENDY), cefepime and zidebactam (ZAYNICH), enlicitide (LIPFENDRA), gedatolisib (REVTORPYK), zidesamtinib (JIDEYTRO) were also curated in DIDB.
You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.
As always, feel free to contact us if you have any questions or comments.